AstraZeneca (AZN)
(Delayed Data from NSDQ)
$73.95 USD
+0.86 (1.18%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $74.02 +0.07 (0.09%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
For AstraZeneca PLC, the company has a dividend yield of 2.82% compared to the Medical - Biomedical and Genetics industry's median yield of zero percent.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
AZN 73.95 +0.86(1.18%)
Will AZN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AZN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AZN
Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?
JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?
AZN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Astrazeneca (AZN) is a Strong Momentum Stock
Sanofi Q2 Earnings & Sales Miss, 2025 Top-Line View Raised, Stock Down
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Other News for AZN
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Trump Trade: Trump signs executive order raising tariff on Canada to 35%
European pharmaceutical stocks slip after Trump pushes for lower drug prices
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
Press Secretary says Trump sent letters today to pharmaceutical companies